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Abstract
The epidemiologically most important mechanism of antibiotic resistance in Staphylococcus
aureus is associated with mecA–an acquired gene encoding an extra penicillin-binding pro-
tein (PBP2a) with low affinity to virtually all β-lactams. The introduction of mecA into the S.
aureus chromosome has led to the emergence of methicillin-resistant S. aureus (MRSA)
pandemics, responsible for high rates of mortality worldwide. Nonetheless, little is known
regarding the origin and evolution of mecA. Different mecA homologues have been identified
in species belonging to the Staphylococcus sciuri group representing the most primitive staphy-
lococci. In this study we aimed to identify evolutionary steps linking these mecA precursors to
the β-lactam resistance gene mecA and the resistance phenotype. We sequenced genomes
of 106 S. sciuri, S. vitulinus and S. fleurettii strains and determined their oxacillin susceptibility
profiles. Single-nucleotide polymorphism (SNP) analysis of the core genome was performed to
assess the genetic relatedness of the isolates. Phylogenetic analysis of the mecA gene homo-
logues and promoters was achieved through nucleotide/amino acid sequence alignments and
mutation rates were estimated using a Bayesian analysis. Furthermore, the predicted structure
of mecA homologue-encoded PBPs of oxacillin-susceptible and -resistant strains were com-
pared. We showed for the first time that oxacillin resistance in the S. sciuri group has emerged
multiple times and by a variety of different mechanisms. Development of resistance occurred
through several steps including structural diversification of the non-binding domain of native
PBPs; changes in the promoters of mecA homologues; acquisition of SCCmec and adaptation
of the bacterial genetic background. Moreover, our results suggest that it was exposure to
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β-lactams in human-created environments that has driven evolution of native PBPs towards a
resistance determinant. The evolution of β-lactam resistance in staphylococci highlights the
numerous resources available to bacteria to adapt to the selective pressure of antibiotics.
Author summary
The emergence and rise of mecA-mediated β-lactam resistance in staphylococci has been
one of the greatest concerns of the scientific and medical communities worldwide. How-
ever, little is known regarding the origin of the mecA gene determinant. In this study we
demonstrate that antibiotic pressure in the human environment and in food additives
used in livestock was the major driving force of the evolution and spread of resistance to
β-lactams. Furthermore, we confirm the previous findings suggesting that the develop-
ment of resistance occurs in primitive species of staphylococci through diversification of a
native penicillin binding protein involved in cell wall synthesis. We also demonstrate that
resistance was achieved through four distinct mechanisms: accumulation of substitutions
in a specific domain of the protein; diversification of the promoter of the gene; acquisition
of SCCmec, and adaptation of the genetic background. Our results highlight the resources
that primitive bacteria used to thrive in a changing environment that has led to the methi-
cillin-resistant Staphylococcus aureus (MRSA) pandemics.
Introduction
The most important antibiotic resistance mechanism in staphylococci is associated with the
mecA gene, which confers resistance to the large class of β-lactam antibiotics. mecA is carried on
a mobile genetic element called staphylococcal cassette chromosome mec (SCCmec) [1], which
always inserts at the same locus in the chromosome, in the 3’ end of orfX (which encodes a RNA
methyltransferase) [1, 2]. Several studies have demonstrated that acquisition of mecA confers to
staphylococci a competitive advantage in the hospital, community and veterinary environments
[3, 4]. Introduction of the mecA determinant into the S. aureus genome on multiple occasions,
has led to the emergence and worldwide dissemination of several methicillin-resistant S. aureus
(MRSA) clones [5].
The mecA determinant encodes an extra penicillin-binding protein (PBP2a). The expres-
sion of resistance is achieved by a slow rate of acylation of PBP2a as well as a low affinity of the
enzyme for β-lactams [6]. Structural studies have revealed that the poor acylation rate, that
PBP2a presents when in contact with β-lactams, is due to a distorted active site, provided by
the flexibility of the non-binding (NB) domain and regions surrounding the active site groove
in the transpeptidase (TP) domain [7]. Furthermore, the position of Ser403 is crucial for the
nucleophilic attack of the β-lactam ring, which leads to acylation of the protein [7].
The first clinical MRSA isolates were identified in the UK in 1961, shortly after the intro-
duction of methicillin into clinical practice [8, 9]. Early MRSA were found to present a hetero-
geneous profile of resistance to β-lactams [10]. Further studies have revealed that mutations in
genes associated with cell division as well as central metabolism (the so-called auxiliary genes)
influence the expression of β-lactam resistance and the resulting phenotype [11]. Moreover,
the expression of homogeneous high level resistance has been associated with the activation of
the bacterial stringent response, provoked by mutations in the relA system [12, 13] and related
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regulons and genes [14]. These findings underline the importance of the S. aureus genetic
background in the expression of β-lactam resistance.
The rapid emergence of MRSA raised the hypothesis that mecA was already present in the
staphylococcal gene pool prior to the introduction of methicillin. In fact, a ubiquitous homo-
logue named mecA1, with 80% nucleotide identity to mecA has been identified in the primitive
coagulase-negative Staphylococcus sciuri [15]. Several lines of evidence suggest that mecA1 is
the precursor of mecA. While mecA1 does not confer resistance to β-lactams in S. sciuri, there
are reports of β-lactam-resistant strains that have alterations in the promoter region of this
gene [16]. When introduced experimentally into a S. aureus strain, mecA1 was able to confer
β-lactam resistance and produce a protein with properties resembling that of MRSA PBP2a
[17, 18]. Additional mecA homologues have been identified in related species, including a
mecA homologue (mecA2) with 90% nucleotide identity with mecA in Staphylococcus vitulinus
[19]. Furthermore, mecA along with its regulators, mecI and mecRI, has been identified in a
small number of Staphylococcus fleurettii isolates [20].
Despite the importance of mecA in the epidemiology of antibiotic resistant staphylococci,
the evolutionary history of this gene has remained unclear. The purpose of this study was to
shed light on the evolutionary steps linking the native mecA homologues identified in primi-
tive coagulase negative staphylococci to the β-lactam resistance gene mecA and the resistance
phenotype.
Results
Homologues of mecA are abundant in S. sciuri, S. vitulinus and S.
fleurettii
The putative precursor of mecA is mecA1, previously shown to be ubiquitous in S. sciuri (15),
but the frequency of the other mecA homologues (mecA2 and mecA) in the remaining species
of the S. sciuri group remained unclear. Additionally, the location of mecA homologues in the
chromosome was unknown.
A search for mecA homologues by BLAST analysis in the genomes of 106 S. sciuri, S. vituli-
nus and S. fleurettii isolates collected from humans and animals showed that all strains carried
at least one copy of mecA homologue. These were found either in the orfX (SCCmec insertion
site) or 200 kb from orfX, a site that from now on, we will call native location. We confirmed
that, in our collection, mecA1 was present in all S. sciuri isolates [15] and mecA was present in
all S. fleurettii strains [20] at the native location. S. vitulinus was different from the other spe-
cies, since half of the strains (n = 9) carried mecA2 [19], and the remaining strains either car-
ried mecA (n = 6) or did not carry any mecA homologue in this region (n = 3).
mecA1 is a hot spot for diversification
Alignment of all mecA1, mecA2 and mecA sequences (S1A Fig) showed that mecA1 was extremely
diverse, including a total of 44 different alleles (SID = 97.2%, CI = 95.7%-98.7%) that varied bet-
ween 93–100% in nucleotide identity (S1B Fig). In contrast, mecA2 and mecA were highly con-
served (mecA2: SID = 70.4%, CI = 60.5%-80.2%; mecA: SID = 21.6%, CI = 9.7%-33.6%) varying
from 99.75 to 100% in nucleotide identity.
Furthermore, amino acid sequence predictions showed that the SID of mecA1-encoded
PBP4 was still very high, 96.2% (CI = 94.5%-97.9%). Interestingly, although both the nonbind-
ing (NB) and transpeptidase (TP) domains were under purifying selection (dN/dS<1), the NB
domain accumulated many more amino acid substitutions (36%) and showed a higher dN/dS
per site (0.19) than the TP domain (8%; dN/dS = 0.05).
Development of β-lactam resistance in primitive staphylococci
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The genetic diversity observed for mecA1 appears to have resulted both from recombination
and mutation events, wherein the average recombination/mutation rate/site was estimated to
be 0.15:1. According to RDP4 analysis, the recombination observed in mecA1 has been driven
by recombination between different S. sciuri mecA1 alleles (Supplementary S1B Fig). Although
according to our data recombination in mecA1 was not such a frequent event, the recombining
mecA1 alleles represented 60.5% of the S. sciuri population. In addition, all but two S. sciuri iso-
lates showing oxacillin resistance carried recombining alleles, suggesting that recombination
in mecA1 was important for the development of resistance in this species.
Overall, neither genetic diversity nor recombination were features affecting the entire S.
sciuri genomes. This was obvious by the lower fraction of conserved positions of mecA1
(84.7%) when compared to the remaining core genes (91.57%; stdev 3.43) (Fig 1A), and by the
fact that mecA1 was among the 2.5% most variable genes in the core genome (see supplemen-
tary S2 Table and Fig 1A). Additionally, for the great majority of strains (n = 57, 75%) the
order of the 1759 core genes was conserved (0 discontinuities in gene order), when compared
with the S. sciuri sciuri reference genome NCTC12103 (see Table 1 and Fig 1B).
The only subspecies that, according to our data, has probably a higher recombination
rate is S. sciuri rodentius, since the genomes of all the strains belonging to this subspecies
showed at least one discontinuity in their genome. Furthermore, this subspecies com-
prised the highest number of discontinuities in gene order (1–5 discontinuites). The other
subspecies showing discontinuities were the subspecies S. sciuri sciuri and a putative new
subspecies (see item The genetic background was associated with the emergence of β-lactam
resistance in S. sciuri)), but this corresponded to a single discontinuity and was a rare
occurrence among these subspecies.
Altogether, these results suggest that mecA1 is a hotspot for diversification in S. sciuri.
Fig 1. Distribution of the percentage of conserved nucleotides among the 1759 core genes of the 76 S.
sciuri strains analyzed in this study. The conservation percentage of mecA1 is shown in red (A). Number of
discontinuities in the order of the core genes in the 76 S. sciuri strains analyzed in this study, when compared to S.
sciuri sciuri reference strain NCTC12103 (B).
https://doi.org/10.1371/journal.pgen.1006674.g001
Table 1. Number of discontinuities in the order of 1759 core genes of the 76 S. sciuri genomes when
compared with the S. sciuri sciuri reference genome NCTC12103.
Discontinuities In Gene Order 0 1 2 3 4 5
Number of Genomes 57 8 1 7 2 1
https://doi.org/10.1371/journal.pgen.1006674.t001
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Different levels of oxacillin resistance were observed in all species of S.
sciuri group
To assess the level of resistance to oxacillin, we determined the epidemiological cut-off (ECOFF)
value for oxacillin in the S. sciuri group of species (S2 Fig), since the currently available MIC
breakpoints are defined only for clinically significant Staphylococcus species. According to this
analysis, the oxacillin breakpoint for resistance was set at 3 μg/ml oxacillin.
Considering this breakpoint, the great majority of S. sciuri strains carrying only mecA1
(54/60) was susceptible to oxacillin, but six strains were resistant (K4, K5, K7, Jug17, SS37
and SS41) as determined by Etests. From the 54 susceptible strains, 24 produced heteroge-
neous profiles when analysed by oxacillin population analysis profiles (PAPs), and almost
half of these isolates (11 out of 24) were able to grow at concentrations up to 6–100 μg/ml
(Fig 2A). Moreover, the 16 S. sciuri strains that carried mecA in addition to mecA1 were all
resistant (MIC 16 to >256 μg/ml), and representative strains showed an heterogeneous pro-
file and were able to survive at concentrations up to 800 μg/ml of oxacillin (Fig 2A and
Table 2).
Like in S. sciuri, in S. vitulinus, the great majority of strains carrying either mecA2 or mecA
were oxacillin-susceptible, but some of these strains showed a heterogeneous profile in which
sub-populations could grow above the MIC (100–400 μg/ml) (Fig 2B). Moreover, a few strains
displayed a resistant phenotype (CH15, CH2 and CH5) (see Table 2 and Fig 2B).
In contrast, the great majority of S. fleurettii isolates were resistant to oxacillin (MIC 4-
>256 μg/ml) with subpopulations that were able to grow at concentrations up to 25–400 μg/
ml (Fig 2C), but two strains showed a susceptible phenotype (CH22 and CH28) (see Table 2
and Fig 2C).
Oxacillin resistance emerged by multiple molecular strategies
In order to understand the mechanisms associated with the oxacillin resistance phenotypes
exhibited by S. sciuri, S. vitulinus and S. fleurettii we looked for: differences in the structure of
proteins encoded by mecA homologues; changes in the expression of mecA homologues; pres-
ence of SCCmec; and differences in the genetic background.
Alteration in the structure of the active site in mecA homologue-encodedPBPs was associ-
ated with β-lactam resistance. To test if the nucleotide diversity of different mecA homo-
logues could explain the different levels of oxacillin susceptibility observed, we compared the
structure of the proteins encoded by different mecA homologues (mecA allele 5, mecA2 allele 2,
mecA1 allele 4, mecA1 allele 17, mecA1 allele 21, mecA1 allele 22, mecA1 allele 25 and mecA1
allele 42) with the structure of PBP2a using a modeling approach. We observed that in multiple
occasions, in S. sciuri, S. vitulinus and S. fleurettii, the level of oxacillin susceptibility could be
related to alterations occurring in the active site grove that could lead to a higher or lower
exposure of the catalytic amino acid Ser403 (PBP2a)/Ser401 (PBP4).
This was the case of the protein encoded by mecA1 allele 42, present in the oxacillin-suscep-
tible S. sciuri carnaticus type strain K11 [22], in which the residues Ser596 and Thr598, were
not located in a β-sheet motif, in contrast to what was found in PBP2a (Fig 3C). The position
of these residues, which surround the active site groove, was otherwise more relaxed, suggest-
ing that access to Ser401 is probably facilitated, explaining the susceptible phenotype observed.
The structures predicted for the remaining mecA1 alleles analyzed were similar. This associa-
tion between the phenotype and the protein structure was likewise found in the S. sciuri strains
Jug17, HSM851 and M2710, carrying allele mecA1 4 (Fig 3D), all showing high-level resistance
to oxacillin, in which Thr598 was much closer to Tyr444, thus “closing” the active site groove
and protecting Ser401 from interacting with the β-lactam ring.
Development of β-lactam resistance in primitive staphylococci
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Fig 2. Oxacillin susceptibility population analysis profiles (PAPs) for representative S. sciuri (A)[15, 21], S.
vitulinus (B) and S. fleurettii (C).
https://doi.org/10.1371/journal.pgen.1006674.g002
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In addition, the protein encoded by the most frequent mecA2 allele (mecA2 2) in S. vituli-
nus, (which is associated with oxacillin susceptibility in almost all strains), had residues Ser403
and Thr600 (Fig 3B) in positions different from those found in PBP2a. This could lead to
higher exposure of Ser403 to the β-lactam ring. The only strain carrying mecA2 allele 2 that
was resistant to oxacillin (CH15) had an alteration in the promoter of the protein (see section
below—Mutations in the promoter of mecA homologues gave rise to β-lactams resistance).
Another example, in S. fleurettii, is the protein encoded by mecA allele 5, associated with
high level of oxacillin resistance that had the exact same residues as S. aureus PBP2a. Although
these residues were not in the exact same position, their orientation was the same (Fig 3A),
suggesting that they should have a similar rate of acylation.
Table 2. Main characteristics of β-lactam resistant strains as defined by the ECCOF of 3 μg/mL.
Strain Date of
isolation
Host MIC μg/ml (eTest/
PAP)
Mechanism of resistance Phylogenetic
group
mec allele Recombinant mecA1
allele
M1234 2009 Human >256 SCCmec S. sciuri new 2 mecA 9 /mecA1 6 +
M692 2007 Human 96 SCCmec S. sciuri new 2 mecA 9 /mecA1 6 +
M2590 2012 Human >256 SCCmec S. sciuri new 2 mecA 9 /mecA1 6 +
M2276 2011 Human >256 SCCmec S. sciuri new 2 mecA 9 /mecA1 6 +
D573 2007 Human >256 SCCmec S. sciuri new 2 mecA 9 /mecA1 6 +
M1653 2010 Human >256 SCCmec S. sciuri new 2 mecA 9 /mecA1 6 +
CH17 2010 Horse >256 SCCmec S. sciuri new 2 mecA 8 /mecA1 7 +
CH18 2010 Horse >256 SCCmec S. sciuri new 2 mecA 8 /mecA1 7 +
M2710 2012 Human >256 SCCmec, altered PBP4 S. sciuri new 2 mecA 7 /mecA1 4 +
HSM851 2010 Human 16 SCCmec, altered PBP4 S. sciuri new 2 mecA 7 /mecA1 4 +
Jug17 2002 Human >256 Altered PBP4 S. sciuri new 2 mecA1 4 +
K3 1992 Human >256 SCCmec/ alterations mecA1
promoter
S. sciuri rodentius mecA10/mecA1 17 +
K4 1992 Human >256 Alterations mecA1 promoter S. sciuri rodentius mecA1 17 +
K5 1992 Human 25 Alterations mecA1 promoter S. sciuri rodentius mecA1 17 +
K7 1992 Human >256 Alterations mecA1 promoter S. sciuri rodentius mecA1 17 +
SS37 1996 Human 25 Alterations mecA1 promoter S. sciuri rodentius mecA1 17 +
SS41 1996 Human 3 Alterations mecA1 promoter S. sciuri rodentius mecA1 17 +
CH16 2010 Human 24 SCCmec S. sciuri rodentius mecA 7 /mecA1 19 +
K6 1992 Human >256 SCCmec S. sciuri rodentius mecA 7 /mecA1 42 -
M1640 2010 Human 96 SCCmec S. sciuri sciuri mecA 7 /mecA1 37 -
Jug1 2002 Dog >256 SCCmec S. sciuri new 1 mecA 7 /mecA1 16 +
M1886 2011 Human 64 SCCmec S. sciuri new 1 mecA 7 /mecA1 43 -
CH2 2004 Horse 4 Genetic background? S. vitulinus mecA 4 -
CH5 2005 Horse >256 Genetic background? S. vitulinus mecA 4 -
CH15 2004 Horse >256 alterations mecA2 promoter S. vitulinus mecA2 2 -
CH19 2010 Horse 8 mecA native location S. fleurettii mecA 1 -
CH20 2010 Horse 6 mecA native location S. fleurettii mecA 3 -
CH21 2010 Horse 4 mecA native location S. fleurettii mecA 2 -
CH23 2010 Horse 4 mecA native location S. fleurettii mecA 2 -
CH24 2010 Horse >256 mecA native location S. fleurettii mecA 2 -
CH25 2010 Horse 4 mecA native location S. fleurettii mecA 6 -
CH26 2010 Horse >256 mecA native location S. fleurettii mecA 2 -
CH27 2010 Horse 4 mecA native location S. fleurettii mecA 2 -
CH29 2010 Horse 4 mecA native location S. fleurettii mecA 2 -
402567 2004 Horse >256 mecA native location S. fleurettii mecA 5 -
https://doi.org/10.1371/journal.pgen.1006674.t002
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Mutations in the promoter of mecA homologues gave rise to β-lactam resistance.
Genetic changes in the mecA1 promoter of S. sciuri strains SS37 and SS41 –namely the inser-
tion of IS256 and a single-nucleotide polymorphism (SNP)–respectively, were previously
reported by Couto et al. to be associated with a resistance phenotype [16]. In our collection, we
additionally identified several cases of alterations in the promoter region (200 bp upstream of
mecA homologues) that were associated both with the expression level of the PBPs and to the
oxacillin susceptibility profile observed.
For instance, the oxacillin-resistant S. sciuri rodentius strains K4, K5 and K7 showed alter-
ations in -10 and -35 sequences when compared to the susceptible strain K11 (see S3 Fig). In
particular, we were able to identify in these strains the same nucleotide alterations previously
reported for the oxacillin resistant SS41 strain [16]. For S. vitulinus, the promoter regions of two
strains carrying the mecA2 allele 2 –one susceptible (CH10) and the other resistant to oxacillin
(CH15)–were compared. Whereas the ribosome binding site (RBS) sequence, GGGAGGG, was
located immediately upstream of mecA2 in strain CH15 (at position -3), this same sequence was
located further upstream (at position -6) in strain CH10. Finally, for S. fleurettii, the promoter
of the susceptible strain (CH28) showed a deletion of 16 bp at position -29 upstream of mecA,
possibly at the -10 region (TATACT), when compared to strain CH22, which expresses a higher
level of heteroresistance (see Fig 2C).
Fig 3. Alignment of the active centre of PBP2a (highlighted in cyan blue) and representative PBPs
putatively encoded by mecA homologues. The structure of the PBP was predicted by Modeller and the
alignment was produced in Pymol. Oxacillin-resistant S. fleurettii 402567 mecA allele 5/PBP2a (A). Oxacillin-
susceptible S. vitulinus CH10 mecA allele 2/PBP2a (B). Oxacillin-susceptible S. sciuri K11 mecA1 allele 42/
PBP2a.1 (C). Oxacillin-resistant S. sciuri JUG17 mecA1 allele 4/PBP2a (D). 1. Ser401/Ser403. 2. Lys404/
Lys406. 3. Tyr444/Tyr446. 4. Ser460/Ser462. 5. Asn464/Asn466. 6. Ser596/Ser598. 7. Thr598/Thr600.
https://doi.org/10.1371/journal.pgen.1006674.g003
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As shown in Fig 4, all the described alterations in the promoter sequence could be associ-
ated with differences in the expression of the mecA homologues encoded proteins. In particu-
lar, expression of mecA1 in resistant S. sciuri strains K4, K5, K7 and of mecA2 in S. vitulinus
strain CH15 was increased when compared to the susceptible strains K11 and CH10. The
expression of mecA in the S. fleurettii susceptible strain CH28 was decreased when compared
to the heterogenous strain CH22.
The association between nucleotide alterations in the sequence of the mecA homologues
and their respective promoter regions and the resistant phenotype to oxacillin, was found to be
statistically significant (p<0.05), suggesting that these associations were not due to chance.
Other factors that are described to influence mecA expression in S. aureus are the regulatory
systems mecI/mecR1 and blaI/blaR1 that are induced in the presence of antibiotic [23, 24]. The
mecA was the only mec homologue in which mecI/mecR1 were found upstream the gene and
although a blaZ homologue was found in the three species (67% aminoacid sequence identity),
it seems not to have the capacity to hydrolyze the β-lactam ring as observed using the nitroce-
fin test. Moreover, no difference in the expression of mec homologues was observed in the
presence of oxacillin by western blotting, which suggests that these regulators in species of the
S. sciuri group do not respond to the same stimulus as in S. aureus.
The presence of SCCmec is associated with β-lactam resistance only in S. sciuri. The
main mechanism of β-lactam resistance is associated with the presence of SCCmec [1]. This ele-
ment occurred in 20% of all S. sciuri analyzed and in all subspecies except S. sciuri carnaticus (see
Table 2) and was always associated with high-level resistance (16<MIC<256) (see Table 2).
Although in SCCmec carrying strains, mecA1 was also present, the majority of mecA1 alleles
(mecA1 6, mecA1 7, mecA1 8, mecA1 37, mecA1 42) and promoters found in these strains were
carried by oxacillin-susceptible strains too, suggesting that SCCmec and not mecA1 is responsible
for the resistance phenotype (see supplemental S1 Table). Three strains carried both SCCmec
and alterations in mecA1 structure (HSM851 and M2710) or promoter (K3), which were identi-
fied above as being possibly associated with resistance. In these cases both mechanisms may be
contributing to the resistance phenotype.
In the other two species SCCmec was either absent (S. fleurettii) or did not confer resistance
to oxacillin (S. vitulinus) (see Table 2 and S3B Fig). The absence of the resistance phenotype, in
S. vitulinus, in spite of the presence of SCCmec is puzzling. However, this is not related to the
lack of mecA expression since, as shown by Western blotting, strain H91, carrying SCCmec,
showed an expression level of the encoded PBP that was higher than the negative control
ATCC12228.
The genetic background was associated with the emergence of β-lactam resistant pheno-
type in S. sciuri. The contribution of several housekeeping genes to the optimal expression of
methicillin resistance was previously described in S. aureus [11, 14], and evidence has been
presented that not all S. aureus lineages are adapted to express methicillin-resistance [25, 26].
The phylogenetic reconstruction based on the number of SNP differences in the core genome
of species of the S. sciuri group revealed the existence of three well-defined phylogenetic groups,
corresponding to each of the three species. While the core genomes of S. fleurettii and S. vitulinus
had an average 3000–9000 SNPs and 4000–7000 SNPs difference, respectively, S. sciuri core
genomes differed in average by 15000 SNPs, (S3A–S3C Fig). Moreover, within S. sciuri species
five different clusters were identified, that probably correspond to five different subspecies: the
three previously described subspecies (S. sciuri sciuri, S. sciuri rodentius and S. sciuri carnaticus)
and two putative new subspecies. The phylogenetic clustering shown might have been influenced
by recombination events occurring in S. sciuri rodentius (see above). However, with the excep-
tion of one strain (K4), all the S. sciuri rodentius strains identified by other methods, like tuf and
16S rDNA sequencing, clustered together in the same large subspecies branch, suggesting that
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genetic recombination must have mainly altered the phylogenetic relationships at the strain level
only, not altering significantly the definition of the subspecies.
The resistance phenotypes were clearly associated with phylogeny, mainly in S. sciuri. The
isolates showing β-lactam resistance were almost exclusively (19/22) confined to S. sciuri
rodentius and S. sciuri subspecies new 2 and to specific clusters within each of these subspecies,
which were distinct from the clusters containing susceptible isolates (p<0.05) (See S3C Fig
and Fig 5). Moreover, resistant strains were distributed along phylogeny according to the
mechanism of resistance involved. While strains showing alterations in promoter were exclu-
sively associated with the subspecies S. sciuri rodentius, those showing alterations in the struc-
ture of the proteins encoded by the mec homologue or having SCCmec structures belonged
mainly (14/17) to the putative subspecies new 2 (Table 2) (p<0.05). These results suggest that
the genetic background was a key factor for the expression of resistance in S. sciuri. However,
the identification of the genetic background factors contributing to resistance were not further
explored.
In contrast to S. sciuri, in which emergence of β-lactam resistance appears to be strongly
associated with phylogeny, strains of S. vitulinus and S. fleurettii, with very few exceptions,
were uniformly susceptible and resistant to β-lactams, respectively (see supplementary S1
Table). However, in these species we could also find examples that illustrate the impact of the
genetic background in β-lactam resistance. In particular, we found that S. fleurettii strains car-
rying the exact same gene allele as susceptible S. vitulinus (like mecA allele 4 and mecA allele 2)
showed in contrast, high-level of resistance to β-lactams.
Human and human created environments were drivers of β-lactam
resistance
S. sciuri is widely disseminated in nature, being found in different animal species and, occa-
sionally, isolated from human infections, whereas S. vitulinus and S. fleurettii host range is
mainly restricted to animals (36–39). Nonetheless, the three species live in environments cre-
ated by humans in which antibiotic usage is frequent, namely in hospitals and farms.
Data resulting from this study provided evidence that antibiotic deployment in these envi-
ronments were probably the drivers of β-lactam resistance development. This is illustrated by
Fig 4. Western blotting of the membrane fraction of S. sciuri, S. fleurettii and S. vitulinus using a polyclonal antibody raised against S. aureus
PBP2a and a polyclonal antibody raised against the amidase (AM) domain of S. aureus Atl protein. Lanes 1 and 14: S. epidermidis strain
ATCC12228; Lanes 2 and 13: S. aureus strain COL; Lane 3: S. sciuri carnaticus strain K11; 4: S. sciuri rodentius strain K7; 5: S. sciuri rodentius strain K5;
6: S. sciuri rodentius strain K4; 7: S. fleurettii strain 402567; 8: S. fleurettii strain CH22; 9: S. fleurettii strain CH28; 10: S. vitulinus strain H91; 11: S. vitulinus
strain CH10; 12: S. vitulinus strain CH15.
https://doi.org/10.1371/journal.pgen.1006674.g004
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the finding that all β-lactam resistant S. sciuri, were collected from human sources or from ani-
mals in close contact with humans (horses and dogs), and not from wild animals (p<0.05).
Moreover, all S. vitulinus and S. fleurettii included in this study originated from animal species
in close contact with humans and were either intrinsically resistant to β-lactams or had the
capacity to develop resistance.
Antibiotic usage is linked to the emergence of β-lactam resistance
Antibiotic resistance is believed to be the result of antibiotic pressure imposed on bacteria.
Bayesian phylogenetic reconstruction was used to explore the association between the time of
emergence of resistant phenotypes and antibiotic use.
The MCC tree resulting from BEAST analysis of mecA homologs using a random molecular
clock and a constant size population model showed that the time to the most recent common
ancestor (tMRCA) of all mecA homologues alleles was estimated to be in 1891 (1845–1976
Fig 5. Evolutionary history of mecA homologue alleles. BEAST analysis of the nucleotide sequence of mecA homologues using the random clock and
constant population models. mecA1 alleles are shown in red, mecA alleles are shown in marine blue and mecA2 alleles are shown in green. Numbers next
to tree branches are the posteriors for the tree. Dashed lines indicate the time of introduction of penicillin and oxacillin into clinical practice in humans. Grey
boxes include the number of resistant isolates within each branch and the associated mechanisms of resistance. Asterisks indicate the clusters in which
recombinant mecA1 alleles were identified.
https://doi.org/10.1371/journal.pgen.1006674.g005
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95%HPD) (see Fig 5), before the introduction of antibiotics in the clinical practice, and that
two clusters split in 1937 (1892–1968 95%HPD), one originating mecA1 and the other mecA2
and mecA (Fig 5 and S1B Fig). The mecA1 began diversifying in 1968 (1951–1986 95%HPD),
which coincided with the emergence of recombining alleles and the emergence of β-lactam
resistance. This was contemporaneous with the use of penicillin and methicillin as a treatment
in humans (1940 and 1960, respectively) and of penicillin as a feed additive in production ani-
mals (1950–1960).
According to our results, the first mecA2 allele emerged in a S. vitulinus strain, approxi-
mately in 1967 (1930–1976 95%HPD). The development of mecA occurred later, in S. fleurettii,
in 1977 (1961–1997 95%HPD), suggesting mecA could have been already present in the popu-
lation when methicillin was first introduced into clinical practice, in 1961. The SCCmec was
estimated to have emerged afterwards (1982–1994 95%HPD) in S. sciuri rodentius [22] (Fig 5).
Once created, SCCmec appears to have been rapidly disseminated to other staphylococcal spe-
cies like S. aureus; coincidently, it was during the 1980s and 1990s that MRSA pandemic clones
began to expand worldwide.
The 95% HPD values obtained for the dates presented are wide, particularly at deeper
nodes, thus comprising considerable uncertainty. This may result from the type of strain col-
lection analyzed, which was non-random and enriched for more recent isolates. Alternatively,
the findings may reflect occurrence of purifying selection and recombination in mecA1. In par-
ticular, leaps of diversity due to recombination in mecA1 or to a weak/mild purifying selection
may have led to the estimation of a date that is posterior to the true date of emergence. How-
ever, the MCC tree based on mecA genes in the absence of recombination sites (and using the
same molecular clock and population models), showed no relevant differences when com-
pared to the tree constructed in the presence of recombination, neither in the population
structure nor in the dating of evolutionary events.
Discussion
The mechanism of β-lactam resistance mediated by mecA in Staphylococcus is one of the most
efficient mechanisms of resistance to antibiotics, providing resistance to virtually all members
of the large class of β-lactams. Several studies have shown that the mecA precursor was a native
gene (mecA1) not providing resistance in Staphylococcus sciuri, the most primitive staphylococ-
cal species [15, 18]. However, the evolutionary steps leading to phenotypic resistance remained
unclear. In this study, we showed that species of the S. sciuri group developed multiple strategies
during their evolutionary history to develop β-lactam resistance including (i) structural diversi-
fication of a native PBP, (ii) changes in the promoter of the mecA homologues, (iii) SCCmec
acquisition and (iv) adaptation of the genetic background.
Although the TP domain has been described as the crucial domain for PBP activity [7], our
results are the first to identify a fundamental role of the NB domain for its full performance. In
particular, we found that alterations in the NB domain of proteins encoded by the mecA homo-
logues can have impact on the level of distortion of the active site groove and on the consequent
access of the substrate (or the antibiotic) to the Ser401/Ser403, the key aminoacid residues at the
catalytic site. The existence of subtle changes in the NB domain of PPBs can give rise to proteins
with different levels of activity. Since the different mecA homologues have a very conserved TP
domain, the evolution from a susceptible to a resistance determinant probably involved alter-
ations mainly in the NB domain of the protein.
An additional mechanism driving β-lactam resistance involved alterations in the promoter
of mecA homologues: either deletions around the RBS site or alterations in -10 and -35 regions.
The association of changes in the promoter with an increased mecA1 expression and a resultant
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resistance phenotype was a phenomenon previously observed in a few strains of S. sciuri [16]. In
this study we confirmed that these type of events probably occurred with a relatively high fre-
quency in the overall S. sciuri population and also in S. vitulinus, during their evolutionary his-
tory. This event occurred in the promoters of mecA1 and mecA2 only, and may represent a
molecular strategy used by the bacteria to circumvent antibiotic pressure, in the absence of a
low affinity PBP. We found a good correlation between the alterations in the promoter of these
genes and both the expression of their encoded proteins as well as the corresponding resistance
phenotypes. A previous study analyzing the mechanism of β-lactam resistance in S. sciuri strains
showed a total correlation of the resistance phenotype with an increase in both mecA1 transcrip-
tion and mecA1-encoded PBP translation (16), suggesting that post-transcriptional and post-
translational regulation, if occurring, appear not to have disturbed the link between the alter-
ations in the promoter and the observed expression of resistance.
Another event associated with the emergence of resistance was the acquisition of SCCmec
by S. sciuri and S. vitulinus. However, in this case the correlation between the phenotype and
the genotype was only observed for S. sciuri. The absence of a resistant phenotype in S. vituli-
nus strains carrying mecA either in the native location or within SCCmec is puzzling. We show
that the susceptibility is not associated with the absence of gene expression, but post-transla-
tional modifications may be involved. Another alternative is that access of the antibiotic to its
target may be blocked, by an unknown mechanism.
In addition, our results demonstrate that–similarly to the case of MRSA [11, 14, 27]–the
genetic background also plays an important role in the expression of β-lactam resistant pheno-
type of this primitive group of staphylococci. The most obvious examples are the absence of
resistant phenotype in the presence of mecA in S. vitulinus and the development of resistance
in particular phylogenetic clusters of S. sciuri. Genes involved in general metabolism were
already shown to play important roles in the expression of β-lactam resistance in S. aureus sug-
gesting an interplay between the overall metabolism and β-lactam resistance [27] [28].
The observation that unknown factors in genetic background are important for the expres-
sion of resistance does not allow to establishing definitely a direct correlation between nucleotide
substitutions observed in the promoter sequence and mec homologue genes and the resistance
phenotype. To substantiate this, an ideal approach would be to test the different promoters and
express the different mec homologue variants in an appropriate S. sciuri genetic background.
However, these studies are very difficult to perform due to the lack of genetic tools available in
this species.
The fact that such diversified mechanisms leading to β-lactam resistance were found in dif-
ferent species of the S. sciuri group together with accumulation of more than one of these
mechanisms at different time points, generating redundancy, are evidence for the persistent
antibiotic pressure that these species experienced during their evolutionary history. Moreover,
the diversification, recombination and purifying selection, observed in mecA1 gene, in opposi-
tion to the remaining chromosome, in the majority of S. sciuri strains further highlights the
specific response of a bacterial species to the environmental pressure by antibiotics.
Antibiotic pressure giving rise to β-lactam resistance appears to be directly linked to expo-
sure to human created environments, since resistance was exclusively observed in clinical iso-
lates of human origin or from production animals, where high doses of antibiotics are generally
used, and absent from wild animals where antibiotic pressure is limited to the level of antibiotics
present in nature. This is in accordance with the Bayesian analysis performed, in which the esti-
mated dates of occurrence of key events in mecA homologues evolution coincided with the time
of introduction of antibiotics in veterinary and human clinical settings [29].
A limitation of this study is the fact that the reconstructed phylogeny of the mecA homo-
logues was based on the Bayesian analysis of genes, which we showed to be under recombination
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and purifying selection. Additionally, it was based on a sampling framework that was non-ran-
dom and that constituted an underrepresentation of S. sciuri, S. vitulinus and S. fleurettIi popula-
tion diversity, namely in host range, dates of isolation and geographic region [30].
Consequently, inexact estimations of the evolutionary path of mecA homologues, mainly of
mecA1, may have been generated, adding uncertainty to the dating of the evolutionary events of
mecA homologs, namely to the existence of overlap between the emergence of resistance pheno-
types and the use of antibiotics.
Overall our data suggest that the first evolutionary steps leading to mecA-mediated β-lactam
resistance in Staphylococcus occurred in the most primitive staphylococcal species by several
molecular mechanisms, in response to β-lactam pressure, both in humans and livestock. These
results highlight the complexity of the evolution of mecA-mediated β-lactam resistance.
Methods
Ethical Statement
Human isolates were obtained as part of routine surveillance and laboratory testing and were
analyzed anonymously. All data was collected in accordance with the European Parliament and
Council decision for the epidemiological surveillance and control of communicable disease in
the European community [31, 32]. Ethical approval and informed consent were for that reason
not required. The animal isolates originated from nasal and skin swabs and bovine milk and
some were collected as part of previous studies in Denmark [33, 34] and Switzerland [19, 35].
According to the national legislations, formal ethical approval was not required since samples
were collected by non-invasive sampling procedures and no animal tissues were collected.
Bacterial strain collection
A collection of 106 staphylococcal isolates, comprising 76 S. sciuri, 18 S. vitulinus and 12 S.
fleurettii was assembled. This is a convenience sample, however, we believe it reasonably repro-
duces the species distribution and diversity of hosts that exist in nature, as previously described
[36–39].
Regarding S. sciuri, 28 isolates were obtained from humans, while the remaining 45 isolates
were recovered from both wild and domesticated mammals (Supplementary S1 Table). Isolates
were collected in different countries (Czech Republic, Denmark, Portugal, Switzerland, Sweden,
former Yugoslavia, Mozambique, Panama and USA) between 1972 and 2012. S. vitulinus and
S. fleurettii isolates were collected from horses and bovine mastitis milk samples, in Denmark,
Switzerland and the Netherlands, in 2004, 2005 and 2010. The S. sciuri isolates were identified at
the species level by 16S rRNA ribotyping and API-Staph (Biomerieux, France). S. fleurettii and S.
vitulinus were identified at the species level by sequencing of 16S rRNA or sodA and Maldi-tof
analysis (Microflex LT, Bruker Daltonics GmbH, Bremen) [19, 35, 40]. Species identification
was confirmed by phylogenetic analysis of tuf gene nucleotide sequence [41].
β-lactam susceptibility
Was assessed by oxacillin Etest (bioMe´rieux, France). The breakpoint for defining susceptibil-
ity was evaluated as suggested by EUCAST (www.eucast.org). An epidemiological cut-off
value (ECOFF) was determined by considering the MIC to oxacillin of S. sciuri and S. vitulinus
isolates not carrying mecA (wild type) and isolates carrying mecA (non-wild type; resistant).
All S. fleurettii strains carried mecA and were therefore considered resistant. The distribution of
MIC values was plotted (S2 Fig) and isolates were considered susceptible when MIC< 3 μg/ml.
Moreover, population analysis profiles (PAPs) for oxacillin were determined for representative
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isolates (28/60 S. sciuri exclusively carrying mecA1, 23/37 isolates carrying mecA, 9/9 isolates
carrying mecA2) as previously described [42]. The PAP results of S. sciuri isolates have already
been published [15, 21].
Whole-genome sequencing and de novo assembly
DNA was extracted using the phenol/chloroform extraction method (S. sciuri) and the DNEasy
Blood & Tissue Kit (S. vitulinus and S. fleurettii) (Qiagen, Limburg, The Netherlands). Se-
quencing was performed using a HiSeq (Illumina, San Diego, USA) with an estimated cover-
age of 40x and a read length of 100 bp. The reads were assembled de novo using VELVET
[43] and VelvetOptimiser (https://github.com/Victorian-Bioinformatics-Consortium/
VelvetOptimiser.git).
Reference genome S. fleurettii 402567
DNA of S. fleurettii 402567 was prepared by phenol/chloroform extraction and was sequenced
using PacBio RS apparatus (Pacific Biosciences, Menlo Park, USA). De novo assembly was per-
formed using HGAP 3 (https://github.com/PacificBiosciences/Bioinformatics-Training/wiki/
HGAP-in-SMRT-Analysis).
A reference genome was produced by combining Illumina and PacBio sequencing data for
a single strain, S. fleurettii isolate 402567. PacBio reads were combined with Illumina reads
obtained for each isolate in CLC Genomics Workbench (Qiagen, Hilden, Germany), using the
Genome Finishing module. The resulting contigs were ordered using the closed genome of
Staphylococcus xylosus, the species most closely related to S. fleurettii with a closed genome
(NCBI accession number CP007208.1; average nucleotide identity with S. sciuri, 78%; S. vituli-
nus, 77.1%; and S. fleurettii, 78.5%). Gaps (eight) were closed by mapping Illumina data of
remaining S. fleurettii strains to the contigs. The resulting closed genome was annotated with
RAST (http://rast.nmpdr.org/).
Estimation of strain-to-strain phylogenies
The reference genome S. fleurettii 402567 was used to perform a SNP analysis of the predicted
core genome of S. sciuri, S. vitulinus and S. fleurettii isolates. SNP analysis was performed using
Stampy (version 1.0.11) where reads were mapped to the reference genome. SNP calling was per-
formed using SAMtools (version 0.1.12), and Neighbor Joining (NJ) analysis was used to assess
the phylogeny. Trees were drawn using FigTree (http://tree.bio.ed.ac.uk/software/figtree/).
Phylogenetic analysis of mecA homologues
Nucleotide sequences of mecA homologues were identified by BLAST analysis and were
extracted from the sequence of the contigs. Alignments with the entire gene or regions corre-
sponding to specific domains were performed with ClustalW [44]. Phylogenetic trees were
constructed with a neighbor-joining algorithm. We used BEAST software (v1.8.3) [45] to
investigate the temporal evolution of mecA homologues. Estimation of substitution rates and
divergence times of the tree internal nodes was performed using the HKY nucleotide substitu-
tion model. The Markov chain Monte Carlo (MCMC) analysis was run up to 107 generations
and checked for convergence by examining that the effective sample size (ESS) values were
greater than 200 for all parameters. Strict, random, uncorrelated and fixed clock models under
a constant population size model were compared for their fit to the data using marginal likeli-
hood (stepping stone and path sampling) (see S3 Table) and Bayes factor (see S4 Table). The
best-fit clock model (random clock) was then tested with the constant size population and the
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exponential growth population models. No significant differences in timescales or tree topol-
ogy were obtained when the two different population size models were used. A burn-in of 10%
was removed of each BEAST run and the maximum clade credibility (MCC) tree was selected
from the posterior tree distribution using the program TreeAnnotator (available as part of the
BEAST package). Final trees were annotated with FigTree (http://tree.bio.ed.ac.uk/software/
figtree/). The BEAST analysis was performed for the entire set of mec homologue sequences
and for the sequences belonging to each mec gene separately. To assess the impact of recombi-
nation on the phylogeny, the same analysis was repeated with the mec gene homologue
sequences from which nucleotides under recombination were deleted (RDP4 software).
Estimation of dN/dS ratios
To verify if the non-binding and the transpeptidase domain of mecA1 were under positive
selection, estimates of overall dN/dS ratios (number of non-synonymous substitutios per site/
number of synonymous substitutions per site) were produced for the nucleotide sequence of
each domain, using the program MEGA6 [46].
Estimation of recombination/mutation rates
RDP4 [47] was used to predict which parts of the mecA homologue sequences were under
recombination and to estimate the mecA1 recombination/mutation rate.
Modeling of protein structure
The structure of representative proteins encoded by the mecA homologues was predicted
using ModWeb (https://modbase.compbio.ucsf.edu/modweb/) [48]. Structures of one mecA
allele, one mecA2 allele and six mecA1 alleles (representing each major clade of the phyloge-
netic tree, 0.015 distance cut off) were obtained. Alignments of the structures modeled with
PBP2a (protein database, PDB code 1MWU) were produced in PyMol (The PyMOL Molecular
Graphics System, Version 1.5.0.3 Schro¨dinger, LLC) and visually inspected for relevant alter-
ations of the protein structure.
Assessment of genetic diversity and synteny of S. sciuri core genes
The genetic diversity of the different mecA homologues was assessed by the Simpson’s index of
diversity (SID) [49], using a confidence interval of 95%. The online tool available at http://
darwin.phyloviz.net/ComparingPartitions/ was used. To find the core genes of the 76 S. sciuri
genomes, we used Prokka [50] and Roary [51]. The sequences of the aligned core genes were
compared using Weblogo version 2.8.2 [52] and the number of conserved positions were
determined for each core gene.
To determine the order of the 1759 core genes in each contig of the 76 S. sciuri assembled
genomes a consensus sequence of each core gene was blasted against the 76 S. sciuri genomes
and the reference genome NCTC12103 and their position assigned. The order of the core
genes in each contig of the 76 genome sequences was compared to the order of the core genes
in the NCTC12103 genome, and the total number of discontinuities was determined using an
in-house script.
Statistical analysis
Association between variables within the data was done using the Qui2 test with 95% confi-
dence level.
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Purification of staphylococcal membrane fraction
S. aureus strain COL, S. epidermidis strain ATCC12228, S. sciuri strains K11, K7, K5 and K4, S.
fleurettii strains 402567, CH22, CH28 and S. vitulinus strains H91, CH10 and CH15, were
grown in 250 ml of TSB at 37˚C with aeration to an OD600nm of 0.7. Cells were harvested,
washed and ressuspended in buffer A (50 mM Tris pH 7.5, 150 mM NaCl, 5 mM MgCl2) with
phenylmethylsulfonyl fluoride (0.5 mM) and submitted to freeze-thaw cycles. All subsequent
steps were performed at 4˚C. Lysostaphin (100 μg/ml), Lysozyme (50 μg/ml), DNase (10 μg/
ml), RNase (10 μg/ml), PMSF (0.5 mM) β-mercaptoethanol (10 mM) were added and the cell
suspensions were incubated on ice for 30 min, followed by 5 cycles of sonication of 30 sec and
2 min intervals. Unbroken cells and cellular debris were removed by centrifugation of 5 min at
5000 g and the resulting supernatants were centrifuged at 50,000 g for 1h and washed in 50
mM phosphate buffer, pH 7.0. The obtained membrane fraction was resuspended in 25mM
phosphate buffer pH 7.0, 1% Triton X-100, 10 mM MgCl2, 20% glycerol. Total protein concen-
tration was determined using the BCA assay (Pierce, Thermo Scientific, USA).
Detection of PBP2a by western blotting
Membrane preparations (50 μg) were separated by SDS polyacrylamide gel electrophoresis
(8% acrylamide-0.06% bisacrylamide) at constant current of 20 mA. The proteins were trans-
ferred onto nitrocellulose Hybond-ECL membranes (GE Healthcare Life Sciences, USA) using
the wet blotting system (Bio-Rad, USA) for 90 min. Membranes were kept on PBS-Tween with
5% low-fat milk O/N and incubated with 5 mM diethyl pyrocarbonate (DEPC), to inhibit
binding of S. aureus protein A to IgG [53] and rabbit polyclonal anti PBP2a antibody (raised
against the synthetic peptide NH2-CGSKKFEKGMKK LGVGEDIPSDYPF; RayBiotech) at
1:1000 dilution for 1 hour. After two washes the membranes were incubated with the anti-rabbit
secondary antibody conjugated to horseradish peroxidase (PerkinElmer, USA) at 1:5000 dilu-
tion for 1 hour. The chemiluminiscent signal was detected using Western Lightning Plus-ECL
(PerkinElmer) and CL-XPosure film (Thermo Scientific). The membrane was incubated in
stripping buffer (62.5 mM Tris-HCL pH 6.7, 100 mM β -mercaptoethanol, 2% SDS) at 50˚C for
30 min and re-hybridized with 5mM DEPC and polyclonal antibody raised against the amidase
domain of S. aureus Atl protein, at 1:1000 dilution for 5h.
Accession numbers
The raw reads of the 106 isolates analyzed in this study and the closed genome of S. fleuretti were
deposited in ENA with the following accession number PRJEB18761.
Supporting information
S1 Table. Epidemiological information of all strains studied. The distribution of the differ-
ent mecA homologue alleles in the population of isolates studied is also shown. Phylogenetic
group (S. sciuri sciuri, S. sciuri rodentius, S, sciuri carnaticus, S. sciuri new subspecies group 1, S.
sciuri new subspecies group 2, S. vitulinus, S. fleurettii), origin of the strains and oxacillin MIC
are also shown. β-lactam resistant strains are highlighted in bold. NB: non-binding domain:
TP: transpeptidase domain.
(DOCX)
S2 Table. Percentage of nucleotide identity and size of the core genes of the 76 S. sciuri iso-
lates from this study.
(XLSX)
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S3 Table. Marginal likelihoods for the strict, fixed, random and uncorrelated molecular
clock models under a constant size population model.
(XLSX)
S4 Table. Bayes factors for the strict, fixed, random and uncorrelated molecular clock
models under a constant size population model.
(XLSX)
S1 Fig. Phylogenetic analysis of the mecA homologues nucleotide sequence. mecA homo-
logues. The sequences of each mec homologue gene was extracted from the de novo assembly
contigs and aligned with ClustalW. The tree was performed with UPGMA method, under the
Jukes-Cantor substitution model, with a bootstrap of 100 replicates. The unrooted tree is
shown (A). Identification of recombination events among mecA1 alleles. The recombinant
parts of mecA1 alleles are clustered apart from the remaining portion of the allele. Moreover, a
color code is applied to identity the putative major parents that were involved in the recombi-
nation events (B).
(TIF)
S2 Fig. Distribution of oxacillin MICs of S. sciuri (A) and S. vitulinus (B) as determined by
Etest. “Wild-type” S. sciuri strains: S. sciuri strains carrying mecA1 only; “Resistant” S. sciuri
strains: S. sciuri strains carrying mecA1 and mecA. “Wild-type” S. vitulinus strains: S. vitulinus
strains carrying mecA2; “Resistant” S. vitulinus strains: S. vitulinus strains carrying mecA.
(TIF)
S3 Fig. Phylogenetic analysis of the core genome of isolates belonging to the sciuri group.
Unrooted phylogenetic tree based on the number of SNP differences found among the pre-
dicted core genome of the strains. The reference genome used was S. fleurettii 402567. S. fleur-
ettii (A). S. vitulinus (B). S. sciuri (C).
(TIF)
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